Status epilepticus (SE) is a major medical emergency, causing more than 35,000 deaths each year in the United States. The four research projects of this Epilepsy Research Center (ERC) at the Medical College of Virginia of Virginia Commonwealth University are focused on the CENTRAL THEME of studying SE. These projects compliment each other and the interaction of multi-disciplined investigators around a common theme greatly enhances the development of new insights and research productivity. The four projects will test specific hypotheses developed to investigate clinical aspects and basic mechanisms of SE are: SE: A Clinical and Epidemiological Study; Pathophysiology and Mortality of SE; Genetic Preponderance of SE in Twin Kindreds; and SE Duration- Dependent Modulation of GABAA Receptor Function. The clinical projects will offer important new insights into the epidemiology of SE in the elderly, the neonatal period, the young child, and different ethnic groups. This research will also produce a SE Outcome Scale for identifying high risk patients that can be used for clinical assessment and future therapeutic interventions. The intensive cardiac and central nervous system (CNS) physiological monitoring will test preliminary evidence that persistent CNS excitability predicts HIGH RISK patients for cardiac abnormalities that may ultimately lead to death in SE. In addition, this research effort has identified non-convulsive SE as a major cause of morbidity and mortality and has developed a prospective data base to evaluate this under recognized form of SE in the comatose patient. Utilizing one of the largest twin registries in the world, studies are proposed that provide the first direct evidence that the development of SE in man is controlled in part by a genetic predisposition. Animal models of SE demonstrate that there is a modulation of the GABAA receptor function that underlies the development of SE intractability and resistance to treatment. Studies indicate that alterations in the gamma amino butyric acid (GABA) receptor function play a major role in the pathogenesis of SE. The accomplishments of this research program are enhanced by the collaboration between committed investigators and research projects. The results from this study will ultimately develop new strategies to offer insights into the pathophysiology of SE and improve the diagnosis and treatment of this severe neurological condition.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS025630-13
Application #
6499339
Study Section
Special Emphasis Panel (ZNS1-SRB-W (01))
Program Officer
Fureman, Brandy E
Project Start
1989-01-01
Project End
2005-01-31
Budget Start
2002-02-01
Budget End
2003-01-31
Support Year
13
Fiscal Year
2002
Total Cost
$1,019,705
Indirect Cost
Name
Virginia Commonwealth University
Department
Neurology
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Deshpande, Laxmikant S; Blair, Robert E; Ziobro, Julie M et al. (2007) Endocannabinoids block status epilepticus in cultured hippocampal neurons. Eur J Pharmacol 558:52-9
Deshpande, Laxmikant S; Sombati, Sompong; Blair, Robert E et al. (2007) Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy. Neurosci Lett 411:11-6
Deshpande, Laxmikant S; Blair, Robert E; Nagarkatti, Nisha et al. (2007) Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus. Exp Neurol 204:705-13
Falenski, K W; Blair, R E; Sim-Selley, L J et al. (2007) Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience 146:1232-44
Carter, Dawn S; Haider, S Naqeeb; Blair, Robert E et al. (2006) Altered calcium/calmodulin kinase II activity changes calcium homeostasis that underlies epileptiform activity in hippocampal neurons in culture. J Pharmacol Exp Ther 319:1021-31
Blair, Robert E; Deshpande, Laxmikant S; Sombati, Sompong et al. (2006) Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. J Pharmacol Exp Ther 317:1072-8
DeLorenzo, Robert J; Sun, David A; Deshpande, Laxmikant S (2006) Erratum to ""Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintenance of epilepsy."" [Pharmacol. Ther. 105(3) (2005) 229-266] Pharmacol Ther 111:288-325
DeLorenzo, Robert J (2006) Epidemiology and clinical presentation of status epilepticus. Adv Neurol 97:199-215
Delorenzo, Robert J; Sun, David A; Deshpande, Laxmikant S (2005) Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol Ther 105:229-66
Singleton, Michael W; Holbert 2nd, William H; Ryan, Matthew L et al. (2005) Age dependence of pilocarpine-induced status epilepticus and inhibition of CaM kinase II activity in the rat. Brain Res Dev Brain Res 156:67-77

Showing the most recent 10 out of 25 publications